Researchers have identified a blood test that may predict the onset of Alzheimer’s symptoms in healthy older adults up to a decade in advance. According to a study published in JAMA, the p-tau217 test measures biomarkers linked to brain plaque and tangle buildup. While the test shows promise for accelerating drug trials, experts caution that it is not yet ready for clinical use in symptom-free individuals.
Predicting Alzheimer’s Risk with the p-tau217 Test
The p-tau217 test tracks specific proteins associated with the neurological damage characteristic of Alzheimer’s disease. Data presented at the Alzheimer’s Association International Conference in London revealed that healthy older adults with the highest levels of p-tau217 faced a 38% risk of developing cognitive impairment within five years. That risk jumped to 78% over a 10-year period.
The study, conducted by the Mass General Brigham team, analyzed 2,684 older adults who were cognitively healthy at the time of enrollment. By tracking these participants from 2004 through last year, researchers observed that 478 individuals eventually developed cognitive impairment. According to Dr. Reisa Sperling, senior author of the study, the test serves as a gauge for how far a patient has progressed in the biological process of amyloid and tau accumulation.
Did you know?
Alzheimer’s disease is marked by two primary brain abnormalities: amyloid plaques that clog neural pathways and tau tangles that lead to the death of neurons. The p-tau217 test specifically measures a form of tau that correlates with the presence of these plaques.
Limitations and Clinical Caution
Despite the strong correlation between high biomarker levels and future symptoms, medical professionals urge restraint. Dr. Reisa Sperling notes that for healthy individuals, receiving these results today would not change current medical advice, which remains focused on healthy habits: eating well, getting adequate sleep, exercising, and staying engaged.
Other researchers echo this caution. In a commentary published in JAMA, Drs. Suzanne Schindler of Washington University in St. Louis and David Wolk of the University of Pennsylvania noted that the 10-year risk estimates are less robust because only a small fraction of the study participants were tracked for that duration. They also highlighted that other health variables, such as heart-related conditions or vascular dementia, can cloud diagnostic accuracy. “These tests are not yet precise enough to guide individualized prognosis,” Schindler and Wolk wrote.
The Role of Biomarkers in Future Drug Development
The primary utility of the p-tau217 test currently lies in clinical research. By identifying high-risk individuals, scientists can enroll the right candidates into trials testing preventative drugs. Jessica Langbaum of the Banner Alzheimer’s Institute in Phoenix emphasized that while the findings are strong, she strongly discourages healthy people from seeking out the test at this time. She noted that the test becomes “really important” only once ongoing studies eventually find a drug that could help people before symptoms begin.
Frequently Asked Questions
- Can I get a p-tau217 test to check for Alzheimer’s today?
The test is currently used to help diagnose people who are already experiencing cognitive problems, but experts like Dr. Reisa Sperling advise healthy individuals to wait until there are actionable treatments available. - What does a high p-tau217 level mean?
High levels indicate a higher biological risk for developing cognitive impairment, but they do not guarantee a dementia diagnosis, as individual health factors vary. - Why is it hard to predict Alzheimer’s?
Many people possess amyloid plaques in their brains but never develop dementia. Predicting the disease is difficult because it involves a complex “tipping point” where amyloid triggers tau tangles.
If you are concerned about cognitive health, focus on modifiable lifestyle factors. Research consistently supports the benefits of aerobic exercise, brain-stimulating activities, and high-quality sleep in maintaining long-term cognitive function.
Have questions about current Alzheimer’s research or how to maintain brain health as you age? Subscribe to our newsletter for the latest updates on medical breakthroughs and wellness strategies.
Worth a look